CN114751833B - Dehydroabietylamine chiral ionic liquid and preparation method and application thereof - Google Patents

Dehydroabietylamine chiral ionic liquid and preparation method and application thereof Download PDF

Info

Publication number
CN114751833B
CN114751833B CN202210306108.8A CN202210306108A CN114751833B CN 114751833 B CN114751833 B CN 114751833B CN 202210306108 A CN202210306108 A CN 202210306108A CN 114751833 B CN114751833 B CN 114751833B
Authority
CN
China
Prior art keywords
dehydroabietylamine
ionic liquid
chiral
alpha
methoxyphenylacetic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210306108.8A
Other languages
Chinese (zh)
Other versions
CN114751833A (en
Inventor
葛利
朱轶
闫晶晶
梁清辉
杨克迪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Guangxi University
Original Assignee
Guangxi University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guangxi University filed Critical Guangxi University
Priority to CN202210306108.8A priority Critical patent/CN114751833B/en
Publication of CN114751833A publication Critical patent/CN114751833A/en
Application granted granted Critical
Publication of CN114751833B publication Critical patent/CN114751833B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/62Quaternary ammonium compounds
    • C07C211/63Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N25/00Investigating or analyzing materials by the use of thermal means
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/02Ortho- or ortho- and peri-condensed systems
    • C07C2603/04Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/22Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
    • C07C2603/26Phenanthrenes; Hydrogenated phenanthrenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The invention belongs to the field of ionic liquid preparation, and in particular relates to dehydroabietylamine chiral ionic liquid, and a preparation method and application thereof, wherein the structure of the dehydroabietylamine chiral ionic liquid is shown as a general formula (I):in the general formula (I), n=3 to 6;is NO 3 、BF 4 、NTf 2 Or PF (physical pattern) 6 One of them. The preparation method of dehydroabietylamine chiral ionic liquid provided by the invention has the advantages of simple salification, no need of complex organic synthesis reaction, simple operation, low cost and easiness in obtaining, and high quaternary ammonium salt content in the product. The dehydroabietylamine chiral ionic liquid has chiral recognition capability on R, S-alpha-methoxy phenylacetic acid.

Description

Dehydroabietylamine chiral ionic liquid and preparation method and application thereof
Technical Field
The invention belongs to the field of ionic liquid preparation, and particularly relates to dehydroabietylamine chiral ionic liquid as well as a preparation method and application thereof.
Background
Ionic liquids are salts composed of organic cations and organic anions or inorganic anions that are in a liquid state at or near room temperature. The ionic liquid has excellent physical and chemical properties, such as low vapor pressure, low volatility, good conductivity, strong polarity, wide electrochemical window and high thermal stability, has better solubility and catalytic performance on a large number of inorganic and organic substances, has a modifiable/modulatable anion-cation structure and can be recycled, so the ionic liquid is considered to be a novel green solvent for replacing common volatile organic solvents, and is widely applied in the chemical industry field.
With the continuous development of ionic liquid design and synthesis technology, some students begin to research the design and introduction of chiral centers in ionic liquids in recent years so as to expand the research field and application range of the ionic liquids. The chiral ionic liquid combines the advantages and characteristics of the ionic liquid and chiral substances, and can be applied to the fields of chiral recognition, asymmetric synthesis, enantiomer resolution, stereoselective polymerization, gas chromatography, NMR shift reagent, liquid crystal and the like. Therefore, the development of chiral ionic liquid has important practical significance in the chiral synthesis field.
At present, a few reports on the aspects of synthesis and application research of chiral ionic liquid exist, but the following problems still exist for the preparation method of dehydroabietylamine chiral ionic liquid: (1) the reaction steps are more, and the process is more complex; (2) the content of quaternary ammonium salt in the product is not high; and (3) the raw materials are not easy to obtain and the price is high.
Disclosure of Invention
The invention aims to solve the technical problems and provides dehydroabietylamine chiral ionic liquid and a preparation method thereof.
The technical scheme of the invention is as follows:
the dehydroabietylamine chiral ionic liquid has a structure shown in a general formula (I):
in the general formula (I), n=3 to 6;is NO 3 - 、BF 4 - 、NTf 2 - Or PF (physical pattern) 6 - One of them.
The method for preparing the dehydroabietylamine chiral ionic liquid comprises the following steps: with side chains of halogenated hydrocarbonsThe quaternary ammonium salt is bonded to the amino of dehydroabietylamine to synthesize chiral ionic liquid A containing secondary amine groups, and the chiral ionic liquid A is respectively combined with AgNO 3 、AgBF 4 、LiNTf 2 Or KPF 6 Performing ion exchange to obtain dehydroabietylamine chiral ionic liquid shown in a general formula (I);
wherein the structural formula of the quaternary ammonium salt with the halogenated hydrocarbon side chain is shown in a general formula (II):
in the general formula (ii), n=3 to 6;
the structural formula of the chiral ionic liquid A is shown as a general formula (III):
in the general formula (iii), n=3 to 6.
The synthetic route is as follows:
further, the method comprises the following steps:
(1) Dissolving dehydroabietylamine and a compound shown in a general formula (II) in acetonitrile, heating to 60-80 ℃ and stirring, dropwise adding ethyl acetate after the reaction is finished, cooling to room temperature for crystallization, and filtering to obtain white crystals; anhydrous Na 2 CO 3 Dispersing in acetonitrile to obtain Na 2 CO 3 Acetonitrile solution, adding the white crystal into the Na in batches under the stirring condition of 50-70 DEG C 2 CO 3 In acetonitrile solution, after reacting for 20-30 h, cooling to room temperature, filtering, taking filtrate, decompressing and drying to obtain white solid, namely the chiral ionic liquid A;
(2) Respectively mixing the chiral ionic liquid A with AgNO 3 、AgBF 4 、LiNTf 2 Or KPF 6 And (3) performing ion exchange to obtain dehydroabietylamine chiral ionic liquid shown in the general formula (I).
Preferably, in the step (2), the chiral ionic liquidBody A and AgNO 3 、AgBF 4 、LiNTf 2 Or KPF 6 The molar ratio of (2) is 1:1.
The application of the dehydroabietylamine chiral ionic liquid in visual chiral recognition of R, S-alpha-methoxyphenylacetic acid comprises the following steps: adding R-alpha-methoxyphenylacetic acid or S-alpha-methoxyphenylacetic acid into dehydroabietylamine chiral ionic liquid shown as a general formula (I) to obtain a mixed solution, heating to 90 ℃, preserving heat for 1h, and then cooling to normal temperature, wherein the mixed solution can be observed after 24 h: the mixed solution of S-alpha-methoxyphenylacetic acid was added to form a gel, and the mixed solution of R-alpha-methoxyphenylacetic acid was added to form a gel.
Further, in the mixed solution, the molar ratio of the R-alpha-methoxyphenylacetic acid or the S-alpha-methoxyphenylacetic acid to the dehydroabietylamine chiral ionic liquid is 1:1.
Further, the concentration of the R-alpha-methoxyphenylacetic acid or the S-alpha-methoxyphenylacetic acid is 0.2mg/mL to 0.7mg/mL.
The beneficial effects of the invention are as follows:
compared with the prior art, the preparation method of the dehydroabietylamine chiral ionic liquid provided by the invention has the advantages of simple salification, no need of complex organic synthesis reaction, simple operation, low cost and easiness in obtaining, and high quaternary ammonium salt content in the product. The dehydroabietylamine chiral ionic liquid has chiral recognition capability on R, S-alpha-methoxy phenylacetic acid.
Drawings
FIG. 1 is a nuclear magnetic resonance C-spectrum of 1.4N-propyltrimethylammonium bromide dehydroabietylamine of the present invention;
FIG. 2 is a nuclear magnetic resonance H-spectrum of 1.4N-propyltrimethylammonium bromide dehydroabietylamine of the present invention;
FIG. 3 is a nuclear magnetic resonance C-spectrum of 1.5N-butyltrimethylammonium bromide dehydroabietylamine of the present invention;
FIG. 4 is a nuclear magnetic resonance H-spectrum of 1.5N-butyltrimethylammonium bromide dehydroabietylamine of the present invention;
FIG. 5 is a nuclear magnetic resonance C-spectrum of 1.6N-hexyltrimethylammonium bromide dehydroabietylamine of the present invention;
FIG. 6 is a nuclear magnetic resonance H-spectrum of 1.6N-hexyltrimethylammonium bromide dehydroabietylamine of the present invention;
FIG. 7 shows a mixed solution containing R-. Alpha. -methoxyphenylacetic acid ((a) and a mixed solution containing S-. Alpha. -methoxyphenylacetic acid (b) of example 6.
Detailed Description
The following description of the technical solutions in the embodiments of the present invention will be clear and complete, and it is obvious that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
EXAMPLE 1.4 Synthesis of N-propyltrimethylammonium bromide dehydroabietylamine
Dehydroabietylamine (10.00 g,0.035 mol) and 3-bromopropyl trimethylammonium bromide (7.56 g,0.029 mol) were dissolved in 100ml acetonitrile, heated to 70℃and reacted with stirring for 48 hours; after the reaction is finished, 100ml of ethyl acetate is dripped, cooled to room temperature for crystallization, and 10.16g of white crystals are obtained by filtration; 2.07g of anhydrous NaCO 3 Dispersing in 50ml acetonitrile to obtain Na 2 CO 3 Acetonitrile solution, the white crystal is added into the Na in portions under the stirring condition of 60 DEG C 2 CO 3 In acetonitrile solution, the mixture is cooled to room temperature after 24 hours of reaction, and the filtrate is filtered and dried under reduced pressure to obtain white solid (8.59 g, yield63.51%), the structural formula of which is shown in formula a.
The results of nuclear magnetic resonance are shown in fig. 1-2 and analyzed as follows:
1 HNMR(500MHz,Methanol-d 4 )δ7.13(d,J=8.2Hz,1H,H-11),6.93(dd,J=8.1,2.1Hz,1H,H-12),6.84(d,J =2.0Hz,1H,H-14),3.46–3.39(m,2H,H-23),3.13(s,9H,H-24),2.89–2.83(m,2H,H-7),2.77(p,J=6.9Hz,1H,H-15),2.68(td,J=6.8,3.3Hz,2H,H-21),2.57(d,J=11.9Hz,1H,H-18α),2.37–2.27(m,2H,H-18β,H-1α), 2.01–1.92(m,2H,H-22),1.87–1.61(m,4H,H-1β,5,6),1.59–1.30(m,4H,H-2,3),1.22–1.15(m,9H,H-16,1 7,20),0.96(s,3H,H-19). 13 CNMR(126MHz,Methanol-d 4 )δ147.32(C-9),145.31(C-13),134.46(C-8),12 6.26(C-14),123.81(C-11),123.35(C-12),65.16(C-23),61.18(C-24),52.29(C-21),47.14(C-18),45.48(C-5),38.43(C-1),37.16(C-10),36.76(C-4),35.91(C-3),33.45(C-15),29.78(C-7),24.37(C-20),23.16(C-1 6),23.14(C-17),22.86(C-22),18.57(C-6),18.51(C-2),18.35(C-19).
EXAMPLE 2 Synthesis of 1.5N-butyltrimethylammonium bromide dehydroabietylamine
Dehydroabietylamine (10.00 g,0.035 mol) and 4-bromobutyl trimethyl ammonium bromide (7.97 g,0.029 mol) were dissolved in 100ml acetonitrile, heated to 70℃and reacted with stirring for 48 hours. After the completion of the reaction, 100ml of ethyl acetate was added dropwise thereto and cooled to room temperature for crystallization, and 8.97g of white crystals were obtained by filtration. 1.78g of anhydrous NaCO 3 Dispersing in 50ml acetonitrile to obtain Na 2 CO 3 Acetonitrile solution, the white crystal is added into the Na in portions under the stirring condition of 60 DEG C 2 CO 3 In acetonitrile solution, the mixture is cooled to room temperature after 24 hours of reaction, and the filtrate is filtered and dried under reduced pressure to obtain white solid (7.56 g, yield53.83%), the structural formula of which is shown in formula b.
The results of nuclear magnetic resonance are shown in fig. 3-4 and analyzed as follows:
1 HNMR(500MHz,Methanol-d 4 )δ7.15(d,J=8.3Hz,1H,H-11),6.95(dd,J=8.2,2.0Hz,1H,H-12),6.87(d,J =2.0Hz,1H,H-14),3.52–3.45(m,2H,H-24),3.22–3.09(m,12H,H-21,25,18α),3.00–2.90(m,3H,H-7,18β) ,2.78(hept,J=6.9Hz,1H,H-15),2.37(dtd,J=13.1,3.4,1.3Hz,1H,H-1α),1.97–1.72(m,7H,H-5,6,22,23),1.69(dtd,J=12.9,3.5,1.3Hz,1H,H-1β),1.51–1.38(m,4H,H-2,3),1.23(s,3H,H-20),1.19(d,J=6.9Hz,6H,H- 16,17),1.14(s,3H,H-19). 13 CNMR(126MHz,Methanol-d 4 )δ146.54(C-9),145.69(C-13),134.07(C-8),1 26.30(C-14),123.66(C-11),123.55(C-12),65.42(C-24),59.65(C-25),52.41(C-21),48.40(C-18),46.54(C-5),37.77(C-1),37.26(C-10),36.06(C-4),35.49(C-3),33.44(C-15),29.25(C-7),24.14(C-20),23.12(C- 16),23.10(C-17),22.09(C-22),20.06(C-6),18.76(C-2),17.93(C-19),17.01(C-23).
EXAMPLE 3 Synthesis of 1.6N-hexyltrimethylammonium bromide dehydroabietylamine
Dehydroabietylamine (10.00 g,0.035 mol) and 6-bromohexyl trimethyl ammonium bromide (8.78 g,0.029 mol) were dissolved in 100ml acetonitrile, heated to 70℃and reacted with stirring for 48 hours. After completion of the reaction, 100ml of ethyl acetate was added dropwise thereto and cooled to room temperature for crystallization, and 8.41g of white crystals were obtained by filtration. 1.59g of anhydrous Na 2 CO 3 Dispersing in 50ml acetonitrile to obtain Na 2 CO 3 Acetonitrile solution, the white crystal is added into the Na in portions under the stirring condition of 60 DEG C 2 CO 3 In acetonitrile solution, the mixture is cooled to room temperature after 24 hours of reaction, and the filtrate is filtered and dried under reduced pressure to obtain white solid (7.16 g, yield48.56%), the structural formula of which is shown in formula c.
The results of nuclear magnetic resonance are shown in fig. 5-6 and analyzed as follows:
1 HNMR(500MHz,Methanol-d 4 )δ7.13(d,J=8.2Hz,1H,H-11),6.93(dd,J=8.2,2.0Hz,1H,H-12),6.84(d, J=2.0Hz,1H,H-14),3.39–3.32(m,2H,H-26),3.14(s,9H,H-27),2.92–2.73(m,3H,H-7,15),2.65–2.53(m,3H,H-21,18α),2.41(d,J=12.0Hz,1H,18β),2.30(dt,J=12.8,3.4Hz,1H,H-1α),1.89–1.29(m,16H,H- 1β,2,3,5,6,22,23,24,25),1.25–1.14(m,9H,h-16,17,20),0.97(s,3H,H-19). 13 CNMR(126MHz,Methan ol-d 4 )δ147.21(C-9),145.33(C-13),134.38(C-8),126.28(C-14),123.82(C-11),123.39(C-12),66.39(C -26),61.25(C-27),52.20(C-21),50.40(C-18),45.89(C-5),38.34(C-1),37.22(C-10),36.56(C-4),35.87(C-3),33.44(C-15),29.76(C-7),28.37(C-25),26.48(C-24),25.77(C-23),24.42(C-20),23.17(C-16,17), 22.46(C-22),18.64(C-6),18.48(C-2),18.25(C-19).
EXAMPLE 4 ion exchange
Dehydroabietylamine (5 mmol) of 1.4N-propyltrimethylammonium bromide of example 1 was reacted with equimolar LiNTf 2 Or KPF 6 Dissolved in water (30 mL),dichloromethane (30 mL) was then added to the above solution, stirred at room temperature for 3 hours, and then left to stand, the dichloromethane phase was separated, washed 3 times with water, and the organic phase was concentrated and dried to give an anion of NTf 2 - Or PF (physical pattern) 6 - DAA-CILs of (C).
EXAMPLE 5 ion exchange
1.4N-propyltrimethylammonium bromide dehydroabietylamine (5 mmol) of example 1 was dissolved in 50% methanol solution, and an equimolar amount of AgNO was added under a dark condition 3 Or AgBF 4 Stirring at room temperature for 24 hr, filtering out precipitate under dark condition, concentrating and drying the filtrate to obtain anion NO 3 - Or BF 4 - DAA-CILs of (C).
Example 6 method for visual chiral identification of R, S-alpha-methoxyphenylacetic acid
Adding R-alpha-methoxyphenylacetic acid or S-alpha-methoxyphenylacetic acid to the anion of example 4 is PF 6 - In DAA-CILs of (1), a mixed solution (wherein the molar ratio of R-alpha-methoxyphenylacetic acid or S-alpha-methoxyphenylacetic acid to dehydroabietylamine chiral ionic liquid is 1:1, and the concentration of R-alpha-methoxyphenylacetic acid or S-alpha-methoxyphenylacetic acid is 0.5 mg/mL) is obtained, then the mixed solution is heated to 90 ℃ for heat preservation for 1 hour and then cooled to normal temperature, and after 24 hours, the mixed solution can be observed: the mixed solution of S-alpha-methoxyphenylacetic acid was added to form a gel, and the mixed solution of R-alpha-methoxyphenylacetic acid was added to form a gel. The difference of the two product states shows that the dehydroabietylamine chiral ionic liquid has chiral recognition capability on R, S-alpha-methoxy phenylacetic acid.
The foregoing description is directed to the preferred embodiments of the present invention, but the embodiments are not intended to limit the scope of the invention, and all equivalent changes or modifications made under the technical spirit of the present invention should be construed to fall within the scope of the present invention.

Claims (3)

1. The application of the dehydroabietylamine chiral ionic liquid in visual chiral recognition of R, S-alpha-methoxyphenylacetic acid is characterized in that the structure of the dehydroabietylamine chiral ionic liquid is shown as a general formula (I):
in the general formula (I), n=3 to 6;is NO 3 - 、BF 4 - 、NTf 2 - Or PF (physical pattern) 6 - Is characterized by comprising the following steps: adding R-alpha-methoxyphenylacetic acid or S-alpha-methoxyphenylacetic acid into dehydroabietylamine chiral ionic liquid shown as a general formula (I) to obtain a mixed solution, heating to 90 ℃, preserving heat for 1h, cooling to normal temperature, and observing after 24 h: the mixed solution of S-alpha-methoxyphenylacetic acid was added to form a gel, and the mixed solution of R-alpha-methoxyphenylacetic acid was added to form a gel.
2. The use according to claim 1, wherein the molar ratio of R- α -methoxyphenylacetic acid or S- α -methoxyphenylacetic acid to dehydroabietylamine chiral ionic liquid in the mixed solution is 1:1.
3. The use according to claim 1, wherein the concentration of R- α -methoxyphenylacetic acid or S- α -methoxyphenylacetic acid is from 0.2mg/mL to 0.7mg/mL.
CN202210306108.8A 2022-03-25 2022-03-25 Dehydroabietylamine chiral ionic liquid and preparation method and application thereof Active CN114751833B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210306108.8A CN114751833B (en) 2022-03-25 2022-03-25 Dehydroabietylamine chiral ionic liquid and preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210306108.8A CN114751833B (en) 2022-03-25 2022-03-25 Dehydroabietylamine chiral ionic liquid and preparation method and application thereof

Publications (2)

Publication Number Publication Date
CN114751833A CN114751833A (en) 2022-07-15
CN114751833B true CN114751833B (en) 2023-10-31

Family

ID=82327050

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210306108.8A Active CN114751833B (en) 2022-03-25 2022-03-25 Dehydroabietylamine chiral ionic liquid and preparation method and application thereof

Country Status (1)

Country Link
CN (1) CN114751833B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941814A (en) * 1973-07-28 1976-03-02 Dynamit Nobel Aktiengesellschaft Process for obtaining D(-)-and L(+)-α-azidophenylacetic acid
CN101475498A (en) * 2009-01-13 2009-07-08 中国林业科学研究院林产化学工业研究所 Preparation method of 3-dehydroabietylamine-2-hydroxypropyl trimethyl ammonium chloride
CN101580472A (en) * 2009-06-24 2009-11-18 广西壮族自治区化工研究院 Resolving agent for 1, 1'-bi-2-naphthol and resolving method thereof
CN102225885A (en) * 2011-04-13 2011-10-26 广西壮族自治区化工研究院 Method for increasing optical purity of alpha-terpineol
CN102807495A (en) * 2012-08-22 2012-12-05 中国林业科学研究院林产化学工业研究所 3-chlorine-2-hydroxypropyl dimethyl dehydroabietic-base ammonium chloride and preparation method thereof
CN102850204A (en) * 2011-06-29 2013-01-02 徐州医学院 Resolution method of (S)-2-arylpropionic acid non-steroidal anti-inflammatory drug
CN113173893A (en) * 2021-04-20 2021-07-27 西南林业大学 Rosin-based chiral quaternary ammonium salt and preparation method thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941814A (en) * 1973-07-28 1976-03-02 Dynamit Nobel Aktiengesellschaft Process for obtaining D(-)-and L(+)-α-azidophenylacetic acid
CN101475498A (en) * 2009-01-13 2009-07-08 中国林业科学研究院林产化学工业研究所 Preparation method of 3-dehydroabietylamine-2-hydroxypropyl trimethyl ammonium chloride
CN101580472A (en) * 2009-06-24 2009-11-18 广西壮族自治区化工研究院 Resolving agent for 1, 1'-bi-2-naphthol and resolving method thereof
CN102225885A (en) * 2011-04-13 2011-10-26 广西壮族自治区化工研究院 Method for increasing optical purity of alpha-terpineol
CN102850204A (en) * 2011-06-29 2013-01-02 徐州医学院 Resolution method of (S)-2-arylpropionic acid non-steroidal anti-inflammatory drug
CN102807495A (en) * 2012-08-22 2012-12-05 中国林业科学研究院林产化学工业研究所 3-chlorine-2-hydroxypropyl dimethyl dehydroabietic-base ammonium chloride and preparation method thereof
CN113173893A (en) * 2021-04-20 2021-07-27 西南林业大学 Rosin-based chiral quaternary ammonium salt and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
"脱氢枞酸/胺基固定化手性离子液体的制备及其对映体的吸附拆分性能";陈雨歆;《中国优秀硕士学位论文全文数据库 工程科技Ⅰ辑》(第2期);B016-2391 *

Also Published As

Publication number Publication date
CN114751833A (en) 2022-07-15

Similar Documents

Publication Publication Date Title
CN109369542A (en) A kind of Quadrupolar hydrogen bond assembly and its synthetic method
CN108178770B (en) Method for synthesizing α -amino boron compound
CN106336350B (en) Fluorine-containing dinaphthyl ethine liquid crystal compound and its preparation method and application
Guo et al. Room-temperature AIE ionic liquid crystals based on diphenylacrylonitrile-imidazole salts
CN114751833B (en) Dehydroabietylamine chiral ionic liquid and preparation method and application thereof
Wang et al. Efficient syntheses of bis (m-phenylene)-26-crown-8-based cryptand/paraquat derivative [2] rotaxanes by immediate solvent evaporation method
CN105367430A (en) Amine derivative containing adamantane structure and preparation method and application thereof
Fan et al. Salen-type nickel (II), palladium (II) and copper (II) complexes having chiral and racemic camphoric diamine components
CN112409374A (en) Preparation method of rigid core direct-connected graphene-like benzophenanthrene discotic liquid crystal and mesomorphism
CN111807970A (en) Method for preparing N-benzylaniline by catalytic oxidation of aniline with polyoxometallate
US5110916A (en) Bis (octaalkylphthalocyaninate) lanthanides
Fondo et al. Dinuclear Co (III)/Co (III) and Co (II)/Co (III) mixed-valent complexes: synthetic control of the cobalt oxidation level
JP7079494B2 (en) New compound and its synthesis method
CN113957461B (en) Electrochemical synthesis method of 1,1' -binaphthyl compound
CN110669529A (en) Color liquid crystal material and application thereof
CN111349121A (en) Cobalt carbonyl complex and preparation method thereof
CN111944513B (en) Low-driving voltage electrochromic material based on quinacridone and preparation method thereof
CN103992327B (en) Solvent thermal reaction one step prepares the method for manganese phthalocyanine crystal
CN111393254A (en) Synthesis method of tetrabromo-neopentane
CN105837521B (en) Bis- bromo- 1,3,4,6,8,9- hexafluoros azophenlyene of 2,7- and its crystal form and preparation method
CN114685469B (en) Thiophene derivative based on 9-phenyl-carbazole and preparation and application thereof
CN108558901A (en) A kind of synthetic method of 9,10- neighbour's naphthyl anthracene -2,3,6,7- tetracarboxylic acid dianhydrides
CN112939789B (en) Preparation method of methyl tributyl ammonium chloride
CN109485654A (en) Bromo triptycene tetracarboxylic acid dianhydride compound and preparation method thereof and polyimides and preparation method thereof
CN102557988B (en) Preparation method of 4-nitro phthalonitrile

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant